SUBSCRIBE: Print / eNewsletter
Urine Test Detects Bladder Cancer Recurrence
A urine test (CellDetect) was able to detect disease recurrence in bladder cancer patients, with a reported sensitivity of 84.4% and specificity of 82.7%.
Tarextumab Gets FDA Orphan Drug Designation for Lung, Pancreatic Cancer
The US Food and Drug Administration has granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and small-cell lung cancer.
FDA Approves Ibrutinib for Waldenström Macroglobulinemia
The FDA has expanded the approved use of ibrutinib (Imbruvica) to include patients with Waldenström macroglobulinemia, a rare type of non-Hodgkin lymphoma.
FDA Approves Blinatumomab for Acute Lymphoblastic Leukemia
The FDA has approved blinatumomab (Blincyto) for the treatment of patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia.
FDA Approves Akynzeo for Chemo-Related Nausea, Vomiting
The FDA has approved combined netupitant and palonosetron (Akynzeo) for the treatment of chemotherapy-related nausea and vomiting in patients with cancer.
FDA Approves Anti-PD-1 Drug for Advanced Melanoma
The FDA granted accelerated approval to pembrolizumab (Keytruda) for treating patients with advanced melanoma who are no longer responding to other drugs.
FDA Approves Avastin for Advanced Cervical Cancer
The US Food and Drug Administration has approved bevacizumab (Avastin) for the treatment of patients with recurrent or metastatic cervical cancer.
FDA Approves Belinostat to Treat Rare Lymphoma
The FDA has approved the drug belinostat to treat patients with relapsed or refractory peripheral T-cell lymphoma.
FDA Approves Ceritinib (Zykadia) for Metastatic Lung Cancer
Earlier today the FDA granted accelerated approval to ceritinib (Zykadia) for the treatment of patients with metastatic ALK-positive non-small-cell lung cancer (NSCLC).
FDA Approves Siltuximab for Castleman Disease
The FDA has approved siltuximab (Sylvant) for the treatment of multicentric Castleman disease, a disorder of the lymph nodes that is similar to lymphoma and often treated with chemotherapy and radiation.